In vitro activity of essential oil of Myrtus communis L. against Helicobacter pylori

International Journal of Antimicrobial Agents

Volumn 30, Issue 6, 2007, Pages 562-563

  Deriu, A ^a   Branca, G ^b   Molicotti, P ^a   Pintore, G ^a   Chessa, M ^a   Tirillini, B ^c   Paglietti, B ^a   Mura, A ^d   Sechi, L A ^a   Fadda, G ^b   Zanetti, S ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d Igiene degli Allevamenti e delle produzioni zootecniche AUSL 2 Olbia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESSENTIAL OIL; LEVOFLOXACIN; METRONIDAZOLE; MYRTUS COMMUNIS EXTRACT; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; DYSPEPSIA; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LETTER; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MYRTLE; NONHUMAN; PRIORITY JOURNAL; STOMACH BIOPSY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; MYRTUS; OILS, VOLATILE;

EID: 35748965284     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.005     Document Type: Letter

References (4)

1. European Helicobacter Study Group. Current European concepts in the management of Helicobacter pylori infections, the Maastricht consensus report. Gut 41 (1997) 8-13
2. Current management of Helicobacter pylori infection-The MAASTRICH III Consensus Report. Gut; 2007.
3. Branca G., Spanu T., Cammarota G., et al. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. Int J Antimicrob Agents 24 (2004) 433-438
4. Graham D.Y. Therapy of Helicobacter pylori: current status and issues. Gastroenterology 118 (2000) 52-58